<DOC>
	<DOC>NCT00649844</DOC>
	<brief_summary>The purpose of this study is to compare the efficacy and safety of ziprasidone and clozapine in schizophrenic patients who are resistant and/or intolerant to antipsychotic treatment</brief_summary>
	<brief_title>A Study Comparing the Efficacy and Tolerability of Ziprasidone vs. Clozapine for the Treatment of Schizophrenia in Patients Who Continue to Have Symptoms on or Cannot Tolerate Other Antipsychotic Drugs</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Ziprasidone</mesh_term>
	<mesh_term>Clozapine</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>CGI S ≥4 PANSS ≥ 80 Inpatients or outpatients Patients with a history of myeloproliferative diseases, history of granulocytopenia, agranulocytosis due to a drug Diagnosis of substance dependence within previous 3 months using DSMIV criteria History of seizure Organic mental disease, including mental retardation or epilepsy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>